Plough

Welcome to the 'Plough' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Plough'.

Latest blogosphere posts tagged “Plough”

• 
  eReleases Press Release Headlines — Authority: 549
  
  1 week ago

• Santarus Shares Boom on FDA Approval of Over-the-Counter Heartburn Drug

  
  Xconomy — Authority: 660
  Biotech , Drugs , Heartburn Luke Timmerman wrote: San Diego-based Santarus (NASDAQ: SNTS ) got some good news late today. The company’s partner, the Schering-Plough unit of Merck, has gotten clearance from the FDA to start selling an over-the-counter version of Santarus’ fast-acting heartburn ...
  1 week ago

• After-Hours Movers 12/01: SNTS, ABCW, RAME, GAME Higher; HEB, SW...

  
  Business Finance & Economy - business.marc8.com — Authority: 166
  Hemispherx BioPharma (AMEX: HEB) 45% LOWER; smashed as FDA recommends another Ampligen study. Says cant approve application in its present form. Click here for the full report. Santarus Inc. read more
  1 week ago

• Ski Vacations and Skiing

  
  Travel, Travel Vacations, Travel City, European Travel and more Informations — Authority: 443
  One will agree to the fact that before embarking on a vacation, a few snippets of information on the preparation and plotting can be of real help. So, if you and your family want to go on a ski vacation, and you don’t know anything about skiing, plot a ski vacation straight away. And, you [...]
  1 week ago

• Dog Diabetes and Vetsulin Recall Issues

  
  Dr. Carols Naturally Healthy Pets Blog — Authority: 111
  I wanted to share this note I received with all of my pet loving friends. I just got this letter from a gentleman whose dog was not only sickened from eating tainted dog food involved in the Menu Pet Food recall, but now is faced with the Vetsulin issue.After eating the tainted Menu dog food, [...]
  2 weeks ago

• Ligand Nabs $2M From Merck

  
  Xconomy — Authority: 660
  Biotech , deals , Life Sciences Luke Timmerman wrote: San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later ...
  2 weeks ago

• NPH Insulin Replaces Recalled Vetsulin for Pet Diabetes

  
  Dr. Carols Naturally Healthy Pets Blog — Authority: 111
  The FDA and Intervet/Schering Plough announced the Vetsulin recall alert last week and I have received several inquiries from diabetic pet owners asking what type of insulin to buy at the pharmacy to replace the Vetsulin for their diabetic pets.Vetsulin, the “special” insulin, labeled for pets, available from ...
  3 weeks ago

• Following Fred: How Hassan Will Spend His Time

  
  Pharmalot — Authority: 580
  Now that Fred Hassan is no longer the chief executive of Schering-Plough - or any other drugmaker - since Merck finally scooped up its rival, Fred has been busy accepting invitations to join the boards of various other corporations. Apparently, his experience selling drugmakers - don’t forget his time running ...
  3 weeks ago

• The Arbiter Study Is Another Setback For Merck

  
  Pharmalot — Authority: 580
  Abbott Labs’ Niaspan appeared safer and more effective that Merck’s Zetia as a secondary cholesterol treatment, according to a study released Sunday night. Funded by Abbott and called Arbiter-6, the study measured thickness of the carotid artery leading to the brain in 208 patients, who were given simvastatin ...
  3 weeks ago

• Drinking this latte sure makes me crave … shoe inserts???

  
  Bizmology — Authority: 125
  Consumer goods manufacturers seem to be taking product advertising to a new level. According a recent Ad Age article , we shouldn’t be surprised if we find ourselves viewing ads for Dr. Scholl’s while enjoying a break at a favorite coffee shop or food chain. Schering-Plough (which changed its name to Merck ...
  3 weeks ago

• Get A Refund If You Took Vytorin Or Zetia [Lawsuits]

  
  Consumerist — Authority: 802
  If you or someone you know were prescribed the high cholesterol drugs Zetia or Vytorin and paid full price or a co-pay, you may be eligible for a refund as part of a recent class-action lawsuit. Manufacturers Merck and Schering-Plough are accused of violating consumer protection laws. While both drugs were marketed as ...
  3 weeks ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 580
  Hello, everyone. A busy day lies ahead as the FDA holds its long-awaited meeting to discuss promotion on the Internet. More on that shortly. Meanwhile, there will also be the usual deadlines and meetings to conquer, so let’s all grab a cup of stimulation and dig in. Hope your day goes well…. Lilly Pays Utah $24M ...
  3 weeks ago

• The day ahead: Thursday

  
  From Reuters.com — Authority: 532
  Wal-Mart sales numbers will hold the spotlight along with results from Walt Disney and Anheuser-Busch InBev. Highlights: *   Wal-Mart is expected to report higher third-quarter earnings, but Wall Street is focused on U.S. sales, which the retailer has stopped reporting on a monthly basis. *  Walt Disney is ...
  4 weeks ago

• Whytorin? Merck Cholesterol Pills Face Another Test

  
  Pharmalot — Authority: 580
  The big drugmaker may encounter its third negative study result within two years for Vytorin and Zetia which, along with Zocor, is a component in the expensive cholesterol pill. The latest trial is scheduled to be presented this coming Monday at the American Heart Association meeting, and pits Merck’s drugs against ...
  4 weeks ago

• (RX) Big Pharma and Biotech – Industry Outlook

  
  Stock Blog Hub — Authority: 459
  The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent ...
  4 weeks ago

• NASCE LA NUOVA MERCK: COMPLETATO IL PROCESSO DI FUSIONE CON SCHERING-PLOUGH CORPORATION

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 151
  Merck & Co., Inc. (NYSE: MRK) ha definito la propria strategia a livello globale a seguito del completamento del processo di fusione tra Merck e Schering-Plough Corporation. La nuova Merck,  che opererà con il nome di MSD al di fuori degli Stati Uniti e del Canada , è unazienda leader a livello ...
  4 weeks ago

• FDA Issues Veterinary Alert for Vetsulin in Cats

  
  Love Your Cat — Authority: 135
  Vetsulin has been used to manage diabetes in our dogs and cats for years. Recently, batches of the crystalline zinc insulin may have made its way into the vetsulin batch. This may affect the duration of activity or have fluctuations in the glucose level. If your pet is receiving vetsulin to control his diabetes, you ...
  4 weeks ago

• Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger

  
  PharmExec Blog — Authority: 118
  Image via Wikipedia After Merck & Co. officially announced its $41.1 billion merger with Schering-Plough yesterday, CEO Richard Clark made it clear his company is still looking to expand through further acquisitions and mergers. According to the Wall Street Journal’s Health Blog : Clark told us ...
  4 weeks ago

• Merck Giveth and Johnson and Johnson Taketh Away

  
  Bio Job Blog — Authority: 417
  I am attending the Annual Biomedical Research Conference for Minority Students (ABRCMS) in sunny Phoenix, AZ where I will be providing career development guidance to undergraduate and graduate students. Ironically, given the dismal job prospects in the life sciences industry for entry level employees, I will be ...
  4 weeks ago

• Pharmalot… Pharmalittle… G’Morning, Luv

  
  Pharmalot — Authority: 580
  Another day, another deadline. That is our motto. And many of you probably relate. Nonetheless, we are happy to greet the morning and look forward to a busy day. We hope things go well for you today. And to help you along, here are a few developments…. CVS/Caremark Reports Higher Profit (Reuters) King ...
  4 weeks ago

Comments about Plough